Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai, China fosunpharma.com

Overview

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is one of the leading healthcare groups in China, engaged in the research, development, manufacture, and marketing of pharmaceutical products. The company focuses on innovation-driven and integrated healthcare solutions, enhancing global pharmaceutical influence.

Therapeutic areas

OncologyInfectious DiseasesCardiovascularCentral Nervous SystemEndocrine

API / Drug Master Files

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • ESLICARBAZEPINE ACETATEActive2023-04-14
  • VALGANCICLOVIR HYDROCHLORIDEActive2021-09-19
  • TREPROSTINIL SODIUM 5.5 HYDRATEActive2021-01-16
  • FAMCICLOVIRActive2020-08-07
  • VALACYCLOVIR HYDROCHLORIDEActive2015-04-02
  • GANCICLOVIRActive2015-04-02

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Northeast Pharmaceutical Group Co., Ltd.
China
Shanghai Desano Pharmaceuticals Co., Ltd.
China
Shanghai Pharmaceuticals Holding Co., Ltd.
China
Apotex Inc.
Canada
Cambrex High Point
United States
Charles River Laboratories International, Inc.
United States
Duopharma Biotech Berhad
Malaysia
Handok Inc.
South Korea

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo